Literature DB >> 1625617

Hepatitis B virus markers in children and staff in Northern Territory schools.

I D Gardner1, X Wan, P A Simms, D A Worswick, C J Burrell, J D Mathews.   

Abstract

OBJECTIVE: To measure the prevalence of hepatitis B virus (HBV) infection in children and staff at Northern Territory schools.
DESIGN: Children in Years 5-7 in 24 selected primary schools were invited, with parental consent, to provide demographic and ethnic details, and a capillary blood sample for tests for hepatitis B surface antigen (HBsAg) and antibody to hepatitis B surface antigen (anti-HBs). School staff participated on a similar basis. PARTICIPANTS: 1104 children, comprising 556 from ethnic groups (originating from the United Kingdom, Ireland and northern Europe) previously reported as "low HBV prevalence", 439 Aboriginal Australians, and 109 from "other" ethnic groups (originating from Asia, the Pacific, the Middle East and southern Europe); and 209 school staff, comprising 180 from "low HBV prevalence" ethnic groups, and 29 from Aboriginal and other ethnic groups.
RESULTS: Prior HBV infection (i.e. serum positive for HBsAg or anti-HBs) was detected in 28.7% of children (46.9% of 439 Aborigines; 13.7% of the 556 children from the "low prevalence" groups and 32.1% of the 109 from the "other" groups). HBsAg was detected in 8.2% of Aboriginal children, in 0.36% of those from "low prevalence" groups, and in 1.8% of those from the "other" groups. Aboriginal children in rural schools had the highest prevalence of HBV: 5.4% were positive for both HBsAg and anti-HBs, and an additional 9.8% were positive for HBsAg alone. In urban schools, the prevalence was highest in the "other" ethnic groups. For school staff, the prevalence of HBV infection was 12.8% for those from "low prevalence" ethnic groups, and 37.9% for those from all remaining groups (including Aborigines).
CONCLUSION: In the Northern Territory the prevalence of past HBV infection is high in children and school staff from ethnic groups previously known to be at higher risk of HBV infection. For students and staff from ethnic backgrounds expected to be at low risk, HBV prevalence is greater than in individuals from similar backgrounds in other parts of Australia. HBV vaccination is now offered to all infants in the Northern Territory. These results also provide a rationale for the more widespread use of HBV vaccine in other situations where significant HBV transmission might occur.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1625617     DOI: 10.5694/j.1326-5377.1992.tb121461.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN: 0025-729X            Impact factor:   7.738


  5 in total

1.  Development of a Culturally Appropriate Bilingual Electronic App About Hepatitis B for Indigenous Australians: Towards Shared Understandings.

Authors:  Jane Davies; Sarah Bukulatjpi; Suresh Sharma; Luci Caldwell; Vanessa Johnston; Joshua Saul Davis
Journal:  JMIR Res Protoc       Date:  2015-06-10

Review 2.  Chronic hepatitis B prevalence among Aboriginal and Torres Strait Islander Australians since universal vaccination: a systematic review and meta-analysis.

Authors:  Simon Graham; Rebecca J Guy; Benjamin Cowie; Handan C Wand; Basil Donovan; Snehal P Akre; James S Ward
Journal:  BMC Infect Dis       Date:  2013-08-31       Impact factor: 3.090

3.  "Only your blood can tell the story"--a qualitative research study using semi-structured interviews to explore the hepatitis B related knowledge, perceptions and experiences of remote dwelling Indigenous Australians and their health care providers in northern Australia.

Authors:  Jane Davies; Sarah Bukulatjpi; Suresh Sharma; Joshua Davis; Vanessa Johnston
Journal:  BMC Public Health       Date:  2014-11-28       Impact factor: 3.295

4.  Hepatitis B immunization for indigenous adults, Australia.

Authors:  Andre Louis Wattiaux; J Kevin Yin; Frank Beard; Steve Wesselingh; Benjamin Cowie; James Ward; Kristine Macartney
Journal:  Bull World Health Organ       Date:  2016-09-16       Impact factor: 9.408

5.  Establishing contemporary trends in hepatitis B sero-epidemiology in an Indigenous population.

Authors:  Jane Davies; Shu Qin Li; Steven Y Tong; Rob W Baird; Miles Beaman; Geoff Higgins; Benjamin C Cowie; John R Condon; Joshua S Davis
Journal:  PLoS One       Date:  2017-09-08       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.